This protocol is judged by an institutional assessment board, an unbiased team that testimonials any clinical trials involving humans. If a review entails a Agenda I drug, after the board approves the protocol as ethical, the researchers really need to submit an application for an investigational new drug (IND) amount through the FDA.“It’s vit